Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Altair Engineering (ALTR) Prices 5.6M Offering of Common Stock at $35 per share
-
Altair Announces Pricing of Follow-on Public Offering
-
Altair Announces Pricing of Follow-on Public Offering
-
Immunogen (IMGN) Prices Upsized Offering at $11
-
Deciphera Pharmaceuticals (DCPH) Prices 4.3 Million Common Shares at $40/Share
-
Steven Madden (SHOO) PT Raised to $59 at Canaccord Genuity
-
MongoDB (MDB) PT Raised to $54 at Canaccord Genuity
-
Everbridge (EVBG) PT Raised to $52 at Canaccord Genuity
-
Okta, Inc (OKTA) PT Raised to $60 at Canaccord Genuity
-
Deciphera Pharmaceuticals Announces Pricing of Public Offering
-
ImmunoGen Announces Pricing of Upsized Public Offering of Common Stock
-
Canaccord Genuity Group Inc. Reports Fourth Quarter Fiscal 2018 Results
-
IQE plc: Block Admission Return
-
Athenahealth CEO steps down; company considers sale
-
Nouveau Monde Graphite Announces $8,000,000 Private Placement
-
Exact Sciences (EXAS) PT Raised to $70 at Canaccord Genuity
-
Zuora Inc. (ZUO) PT Raised to $26 at Canaccord Genuity
-
Immunogen (IMGN) Plans 12M Share Offering of Common Stock
-
ImmunoGen Announces Proposed Public Offering of Common Stock
-
UPDATE: Smartsheet Inc. (SMAR) PT Raised to $29 at Canaccord Genuity
-
T2 Biosystems Announces Closing of Public Offering of Common Stock
-
Teladoc (TDOC) PT Raised to $63 at Canaccord Genuity Following Acquisition
-
Altair Engineering (ALTR) Announces Proposed 5.6M Class A Share Follow-On Offering
-
Altair Announces Launch of Proposed Follow-on Public Offering
-
Altair Announces Launch of Proposed Follow-on Public Offering
-
Sesen Bio Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares of Common Stock
-
EverQuote Files Registration Statement for Proposed Initial Public Offering of Class A Common Stock
-
Canaccord Genuity Reiterates Buy on bluebird bio (BLUE)
-
AGM Statement
-
Genomic Health Inc. (GHDX) PT Raised to $45 at Canaccord Genuity
-
New Stratus Energy Announces Proposed Acquisition and Private Placement Offering of Subscription Receipts
-
Acasta Enterprises Completes Sale of JemPak and Reduction of its Indebtedness
-
Award of Options
-
Zuora Inc. (ZUO) PT Raised to $23 at Canaccord Genuity
-
TransGlobe Energy Corporation Announces Intention to List on AIM
-
Lululemon Athletica Inc. (LULU) PT Raised to $97 at Canaccord Genuity
-
Neuronetics, Inc., Maker of NeuroStar® Advanced Therapy, Announces Filing of Registration Statement for Proposed Initial Public Offering
-
Neuronetics Files $86M IPO; Plans to List Under Symbol 'STIM'
-
New Stratus Energy Announces Proposed Acquisition and Private Placement Offering of Subscription Receipts
-
Canaccord Genuity Assumes GrubHub Inc. (GRUB) at Buy (Earlier)
-
Financial 15 Split Corp. Completes Overnight Offering of $104,211,800
-
UPDATE: Zillow Group (ZG) Assumed Buy at Canaccord Genuity
-
T2 Biosystems (TTOO) Prices 6.1M Shares at $7.50
-
T2 Biosystems Announces Pricing of Public Offering of Common Stock
-
Sesen Bio (SESN) Prices 22.22M Share Common Offering at $1.80/Sh
-
Box, Inc. (BOX) PT Raised to $30 at Canaccord Genuity
-
HEICO (HEI) PT Raised to $105 at Canaccord Genuity
-
Dick's Sporting Goods (DKS) PT Raised to $34 at Canaccord Genuity
-
Canaccord Genuity Upgrades Biogen (BIIB) to Buy
-
Descartes (DSGX) PT Raised to $35 at Canaccord Genuity

